Yahoo
NasdaqGS - Delayed Quote USD

Vertex Pharmaceuticals Incorporated (VRTX)

546.12 -11.84 (-2.12%)
At close: September 4 at 4:00:00 PM EDT
546.00 -0.12 (-0.02%)
After hours: September 4 at 7:51:59 PM EDT
Trade VRTX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
12,587,200
12,001,300
11,020,100
9,869,200
8,930,700
Cost of Revenue
1,762,800
1,651,300
1,530,500
1,262,200
1,080,300
Gross Profit
10,824,400
10,350,000
9,489,600
8,607,000
7,850,400
Operating Expense
6,047,800
5,795,600
9,723,000
4,826,600
3,600,500
Operating Income
4,776,600
4,554,400
-233,400
3,780,400
4,249,900
Net Non Operating Interest Income Expense
476,400
477,600
567,500
570,600
89,800
Other Income Expense
21,500
-388,800
-85,600
28,800
-107,300
Pretax Income
5,274,500
4,643,200
248,500
4,379,800
4,232,400
Tax Provision
869,300
690,000
784,100
760,200
910,400
Net Income Common Stockholders
4,405,200
3,953,200
-535,600
3,619,600
3,322,000
Diluted NI Available to Com Stockholders
4,405,200
3,953,200
-535,600
3,619,600
3,322,000
Basic EPS
17.31
15.46
-2.08
14.05
12.97
Diluted EPS
17.17
15.32
-2.08
13.89
12.82
Basic Average Shares
254,250
255,700
257,900
257,700
256,100
Diluted Average Shares
256,250
258,000
257,900
260,500
259,100
Total Operating Income as Reported
4,777,100
4,173,300
-232,900
3,832,000
4,307,400
Total Expenses
7,810,600
7,446,900
11,253,500
6,088,800
4,680,800
Net Income from Continuing & Discontinued Operation
4,405,200
3,953,200
-535,600
3,619,600
3,322,000
Normalized Income
4,404,782.41
4,277,666.86
-535,995
3,576,978.40
3,276,862.50
Interest Income
489,700
490,900
598,100
614,700
144,600
Interest Expense
17,000
13,300
30,600
44,100
54,800
Net Interest Income
476,400
477,600
567,500
570,600
89,800
EBIT
4,878,700
4,656,500
279,100
4,423,900
4,287,200
EBITDA
5,100,800
4,866,300
486,300
4,605,200
4,435,500
Reconciled Cost of Revenue
1,762,800
1,651,300
1,530,500
1,262,200
1,080,300
Reconciled Depreciation
222,100
209,800
207,200
181,300
148,300
Net Income from Continuing Operation Net Minority Interest
4,405,200
3,953,200
-535,600
3,619,600
3,322,000
Total Unusual Items Excluding Goodwill
500
-381,100
500
51,600
57,500
Total Unusual Items
500
-381,100
500
51,600
57,500
Normalized EBITDA
5,100,300
5,247,400
485,800
4,553,600
4,378,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
82.41
-56,633.14
105
8,978.40
12,362.50
12/31/2022 - 7/24/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: